"A family of three patents surrounding Veyonda, including one pertaining to use with chemotherapy, has entered the global national phase following a review by the International Examiner."
and what has the International examiner said in its review?
Not the first initial opinion, but now a chapter 1 examination. I suggest you go look them up yourself. Easy to find.
Here is one to start with (IB/373) International Preliminary Report on Patentability Chapter I on (WO2017181242) CHEMOTHERAPY IMPROVEMENTS claims 1-28 inventive step NONE.
https://patentscope.wipo.int/search...ing=FP:(noxopharm)&recNum=2&maxRec=12
Ann: NOX announces Positive Data from CEP-1 Study of Veyonda, page-4
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $4.773K | 48.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20574 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 38542 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
